Physician

Aleksandar Adzic, M.D.

According to 2025 Medicare claims, Aleksandar Adzic, M.D. (NPI: 1063658078) practices advanced heart failure and transplant cardiology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Kings, NY. This provider's primary affiliated billing organization is MAIMONIDES CARDIOLOGY FPP (NPI: 1477803385; TIN: 90-0883864) and primary practice location at 11219-2916. Adzic is affiliated with the Community Care of Brooklyn IPA, Inc. (ACO ID: A4723), participating under the MSSP model.

Adzic's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 640 traditional Medicare patients, billed 1,372 HCPCS/CPT codes, and received $72,634 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 3,201 prescription claims across 168 beneficiaries totaling $1,231,328 in drug costs, led by Entresto (Sacubitril/Valsartan). DME data shows 93 claims. Open Payments data shows 23 records totaling $529. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $52,207 to $1,231,328. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $7,129 and ending at $27,895.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,009	1,692	$72,091
2016	1,047	1,858	$76,371
2017	1,152	2,096	$80,359
2018	896	1,854	$87,739
2019	917	1,967	$83,886
2020	1,046	2,110	$85,165
2021	1,028	2,020	$90,126
2022	1,193	2,130	$79,347
2023	963	1,883	$83,971
2024	640	1,372	$72,634

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	47	415	$52,207
2016	70	562	$39,846
2017	88	1,126	$207,502
2018	131	1,855	$345,898
2019	152	2,032	$272,633
2020	133	2,149	$733,620
2021	139	2,201	$706,545
2022	166	1,849	$649,655
2023	179	2,918	$1,070,795
2024	168	3,201	$1,231,328

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	111	$88,052
2016	N/R	239	$106,547
2017	N/R	197	$13,625
2018	N/R	145	$36,259
2019	N/R	330	$37,790
2020	N/R	702	$61,873
2021	N/R	110	$11,850
2022	N/R	N/R	N/R
2023	N/R	67	$42,482
2024	N/R	93	$8,851

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	72	77	$115
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	52	177	$105
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	105	227	$70
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	47	68	$47
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	417	528	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Entresto	Sacubitril/Valsartan	409	15,964	$349,192
Eliquis	Apixaban	203	9,630	$185,399
Farxiga	Dapagliflozin Propanediol	207	9,516	$157,334
Veltassa	Patiromer Calcium Sorbitex	92	3,754	$119,926
Xarelto	Rivaroxaban	24	1,200	$22,074

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J2260	Injection, milrinone lactate, 5 mg	N	N/R	33	$4,482
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	31	$3,792
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	29	$576

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	23	$529	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aleksandar Adzic, M.D.?

Tedicare shows public-source Medicare data for Aleksandar Adzic, M.D. (NPI 1063658078), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aleksandar Adzic, M.D. have ACO affiliation data?

Aleksandar Adzic, M.D. is shown with ACO affiliation data for Community Care of Brooklyn IPA, Inc. (MSSP, ACO ID A4723).

What billing organization is linked to Aleksandar Adzic, M.D.?

Aleksandar Adzic, M.D. is linked to MAIMONIDES CARDIOLOGY FPP (billing NPI 1477803385) in the available physician profile data.

Does Aleksandar Adzic, M.D. have Open Payments data?

Aleksandar Adzic, M.D. has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.